Aurinia Pharmaceuticals Inc (AUPH)
9.20
-0.05
(-0.54%)
USD |
NASDAQ |
Dec 27, 16:00
9.215
+0.02
(+0.16%)
After-Hours: 20:00
Aurinia Pharmaceuticals Free Cash Flow: 28.30M for Sept. 30, 2024
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Edesa Biotech Inc | -4.890M |
| Lexaria Bioscience Corp | -5.148M |
| Xenon Pharmaceuticals Inc | -158.99M |
| ESSA Pharma Inc | -22.72M |
| ImmunoPrecise Antibodies Ltd | -6.657M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 17.03M |
| Cash from Investing (Quarterly) | -10.57M |
| Cash from Financing (Quarterly) | -2.722M |
| Free Cash Flow Per Share (Quarterly) | 0.116 |
| Free Cash Flow to Equity (Quarterly) | 16.90M |
| Free Cash Flow to Firm (Quarterly) | 16.90M |
| Free Cash Flow Yield | 2.13% |